A genetic perspective on coeliac disease

Trends in Molecular Medicine

Volumn 16, Issue 11, 2010, Pages 537-550

  Trynka, Gosia ^a   Wijmenga, Cisca ^a   van Heel, David A ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CELIAC DISEASE; GENE EXPRESSION; GENETIC RISK; HERITABILITY; HLA SYSTEM; HUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

CELIAC DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-DQ ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

EID: 78049286294     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.09.003     Document Type: Review

References (94)

1. Maki M., et al. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 2003, 348:2517-2524.
2. D'Amico M.A., et al. Presentation of pediatric celiac disease in the United States: prominent effect of breastfeeding. Clin. Pediatr. 2005, 44:249-258.
3. Rampertab S.D., et al. Trends in the presentation of celiac disease. Am. J. Med. 2006, 119:355.
4. Green P.H. The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology 2005, 128:S74-78.
5. Al-toma A., et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007, 56:1373-1378.
6. Biagi F., Corazza G.R. Mortality in celiac disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:158-162.
7. Rubio-Tapia A., et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009, 137:88-93.
8. Godfrey J.D., et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010, 139:763-769.
9. Molberg O., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 1998, 4:713-717.
10. Jabri B., Sollid L.M. Tissue-mediated control of immunopathology in coeliac disease. Nat. Rev. Immunol. 2009, 9:858-870.
11. Sollid L.M., et al. Evidence for a primary association of celiac disease to a particular HLA-DQ (alpha)/(beta) heterodimer. J. Exp. Med. 1989, 169:345-350.
12. Spurkland A., et al. HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. Hum. Immunol. 1992, 35:188-192.
13. Arentz-Hansen H., et al. The intestinal T cell response to (alpha)-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 2000, 191:603-612.
14. Nilsen E.M., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 115:551-563.
15. Green P.H., Cellier C. Celiac disease. N. Engl. J. Med. 2007, 357:1731-1743.
16. Meresse B., et al. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 2004, 21:357-366.
17. Dieterich W., et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 1997, 3:797-801.
18. Tye-Din J.A., et al. Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease. Sci. Transl. Med. 2010, 2:41ra51.
19. Dubois P.C.A., et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 2010, 42:295-302.
20. Price P., et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 1999, 167:257-274.
21. Nistico L., et al. Concordance, disease progression, and heritability of coeliac disease in Italian twins. Gut 2006, 55:803-804.
22. Van Heel D.A., et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 2007, 39:827-829.
23. Hunt K.A., et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 2008, 40:395-402.
24. Trynka G., et al. Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-(kappa)B signalling. Gut 2009, 58:1078-1083.
25. Smyth D.J., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 2008, 359:2767-2777.
26. Garner C.P., et al. Replication of celiac disease UK genome-wide association study results in a US population. Hum. Mol. Genet. 2009, 18:4219-4225.
27. Nejentsev S., et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009, 324:387-389.
28. Minamoto S., et al. Cloning and functional analysis of new members of STAT induced STAT inhibitor (SSI) family: SSI-2 and SSI-3. Biochem. Biophys. Res. Commun. 1997, 237:79-83.
29. Zhernakova A., et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am. J. Hum. Genet. 2010, 86:970-977.
30. Bauquet A.T., et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH -17 cells. Nat. Immunol. 2009, 10:167-175.
31. Yoshinaga S.K., et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int. Immunol. 2000, 12:1439-1447.
32. Minguet S., et al. The extracellular part of (zeta) is buried in the T cell antigen receptor complex. Immunol. Lett. 2008, 116:203-210.
33. Bettelli E., et al. Induction and effector functions of TH17 cells. Nature 2008, 453:1051-1057.
34. Fina D., et al. Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology 2008, 134:1038-1048.
35. Yamanouchi J., et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 2007, 39:329-337.
36. Klein L., et al. Antigen presentation in the thymus for positive selection and central tolerance induction. Nat. Rev. Immunol. 2009, 9:833-844.
37. Allen P.M. Themis imposes new law and order on positive selection. Nat. Immunol. 2009, 10:805-806.
38. Zamisch M., et al. The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus. J. Exp. Med. 2009, 206:2685-2699.
39. Wang J., Fu Y.X. LIGHT (a cellular ligand for herpes virus entry mediator and lymphotoxin receptor)-mediated thymocyte deletion is dependent on the interaction between TCR and MHC/self-peptide. J. Immunol. 2003, 170:3986-3993.
40. Londei M., et al. Gliadin as a stimulator of innate responses in celiac disease. Mol. Immunol. 2005, 42:913-918.
41. Honda K., Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 2006, 6:644-658.
42. Miller S.D., et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
43. Munz C., et al. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 2009, 9:246-258.
44. Stene L.C., et al. Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. Am. J. Gastroenterol. 2006, 101:2333-2340.
45. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49-62.
46. Romanos J., Wijmenga C. Predicting susceptibility to celiac disease by genetic risk profiling. Ann. Gastroenterol. Hepatol. 2010, 1:11-18.
47. Romanos J., et al. Analysis of HLA and non-HLA alleles can identify individuals at high risk for celiac disease. Gastroenterology 2009, 137:834-840.
48. Norris J.M., et al. Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease. J. Am. Med. Assoc. 2005, 293:2343-2351.
49. Zhernakova A., et al. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 2009, 10:43-55.
50. Coenen M.J.H., et al. Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum. Mol. Genet. 2009, 18:4195-4203.
51. Somers E.C., et al. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology 2006, 17:202-217.
52. Eaton W.W., et al. Epidemiology of autoimmune diseases in Denmark. J. Autoimmun. 2007, 29:1-9.
53. Barera G., et al. Occurrence of celiac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2002, 109:833-838.
54. Hindorff L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:9362-9367.
55. Elbers C.C., et al. Using genome-wide pathway analysis to unravel the etiology of complex diseases. Genet. Epidemiol. 2009, 33:419-431.
56. Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005, 128:S68-73.
57. Park J.H., et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet. 2010, 42:570-575.
58. Frazer K.A., et al. Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 2009, 10:241-251.
59. Cirulli E.T., Goldstein D.B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat. Rev. Genet. 2010, 11:415-425.
60. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N. Engl. J. Med. 2010, 363:166-176.
61. Huang, da W., et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
62. Kottgen A., et al. New loci associated with kidney function and chronic kidney disease. Nat. Genet. 2010, 42:376-384.
63. Levy D., et al. Genome-wide association study of blood pressure and hypertension. Nat. Genet. 2009, 41:677-687.
64. Newton-Cheh C., et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 2009, 41:666-676.
65. Cui R., et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 2009, 137:1768-1775.
66. Ganesh S.K., et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat. Genet. 2009, 41:1191-1198.
67. Kamatani Y., et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 2010, 42:210-215.
68. Gudbjartsson D.F., et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat. Genet. 2009, 41:342-347.
69. Barrett J.C., et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat. Genet. 2009, 41:703-707.
70. Imielinski M., et al. Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat. Genet. 2009, 41:1335-1340.
71. De Jager P.L., et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 2009, 41:776-782.
72. Parkes M., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 2007, 39:830-832.
73. Barrett J.C., et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008, 40:955-962.
74. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.
75. Todd J.A., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat. Genet. 2007, 39:857-864.
76. Cooper J.D., et al. Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat. Genet. 2008, 40:1399-1401.
77. Gregersen P.K., et al. REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat. Genet. 2009, 41:820-823.
78. Radstake T.R., et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat. Genet. 2010, 42:426-429.
79. Yang W., et al. Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet. 2010, 6:e1000841.
80. Han J.W., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet. 2009, 41:1234-1237.
81. Raychaudhuri S., et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat. Genet. 2009, 41:1313-1318.
82. McGovern D.P., et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet. 2010, 42:332-337.
83. Reveille J.D., et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 2010, 42:123-127.
84. Plenge R.M., et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 2007, 39:1477-1482.
85. Stein J.L., et al. Voxelwise genome-wide association study (vGWAS). Neuroimage 2010, 15:1160-1174.
86. Han J., et al. A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet. 2008, 4:e1000074.
87. Di Bernardo M.C., et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 2008, 40:1204-1210.
88. Sulem P., et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat. Genet. 2007, 39:1443-1452.
89. Nan H., et al. Genome-wide association study of tanning phenotype in a population of European ancestry. J. Invest. Dermatol. 2009, 129:2250-2257.
90. Grant S.F., et al. Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes. Diabetes 2009, 58:290-295.
91. Simon-Sanchez J., et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 2009, 41:1308-1312.
92. Gieger C., et al. Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet. 2008, 4:e1000282.
93. Jin Y., et al. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N. Engl. J. Med. 2010, 362:1686-1697.
94. Codd V., et al. Common variants near TERC are associated with mean telomere length. Nat. Genet. 2010, 42:197-199.